Bedminster, NJ, United States of America

Sukanthini Thurairatnam

USPTO Granted Patents = 10 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 27(Granted Patents)

Location History:

Bedminster, NJ (US) (2005 - 2012)
Bridgewater, NJ (US) (2021)

Company Filing History:

7 out of 207

Aventis Pharmaceuticals Inc.

patents

5 out of 40

Axys Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2005-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098056 - UDP glycosyltransferase inhibitors and methods of use (2021-08-24),

2. 8258130 - Pyrimidine hydrazide compounds as PGDS inhibitors (2012-09-04),

3. 8202863 - Pyrimidine amide compounds as PGDS inhibitors (2012-06-19),

4. 7482448 - Compounds and compositions as cathepsin inhibitors (2009-01-27),

5. 7226921 - Compounds and compositions as cathepsin S inhibitors (2007-06-05),

6. 7196099 - Compounds and compositions as cathepsin inhibitors (2007-03-27),

7. 7148215 - Chemical compounds (2006-12-12),

8. 7064123 - Compounds and compositions as cathepsin inhibitors (2006-06-20),

9. 7030116 - Compounds and compositions as cathepsin inhibitors (2006-04-18),

10. 6977256 - Compounds and compositions as cathepsin S inhibitors (2005-12-20),

Title: Sukanthini Thurairatnam: Innovator in Pharmaceutical Compounds

Introduction

Sukanthini Thurairatnam is a notable inventor based in Bedminster, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target allergic and inflammatory disorders. With a total of nine patents to his name, his work has the potential to impact many lives.

Latest Patents

Thurairatnam's latest patents include innovative compounds aimed at treating various health conditions. One of his notable inventions is the Pyrimidine hydrazide compounds as PGDS inhibitors. This invention focuses on a compound that can be used in pharmaceutical compositions to treat allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD). Another significant patent is the Pyrimidine amide compounds as PGDS inhibitors, which shares a similar focus on treating allergic and inflammatory disorders.

Career Highlights

Throughout his career, Sukanthini Thurairatnam has worked with prominent companies in the pharmaceutical industry. He has been associated with Aventis Pharmaceuticals Inc. and Axys Pharmaceuticals, Inc., where he contributed to various research and development projects. His expertise in creating pharmaceutical compounds has established him as a valuable asset in the field.

Collaborations

Thurairatnam has collaborated with several professionals during his career. Notable coworkers include David John Aldous and Michael Gra

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

2 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.